# Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software

> **NCT07078071** · NA · COMPLETED · sponsor: **Huawei Device Co., Ltd** · enrollment: 199 (actual)

## Conditions studied

- Arrhythmia, Heart

## Interventions

- **DEVICE:** ECG

## Key facts

- **NCT ID:** NCT07078071
- **Lead sponsor:** Huawei Device Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-18
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07078071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07078071, "Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07078071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*